Catalyst Pharmaceuticals, Inc. et al v. Inventia Healthcare Limited
| Catalyst Pharmaceuticals, Inc. and SERB SA |
| Inventia Healthcare Limited |
| 1:2023cv01331 |
| November 20, 2023 |
| US District Court for the District of Delaware |
| Jennifer Choe-Groves |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on December 8, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 11 FINAL Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 10,626,088 ;US 10,793,893 ;US 11,060,128 ;US 11,268,128 ;US 11,274,331 ;US 11,274,332. (apk) |
Filing 10
ORDER: Plaintiffs' Complaint, ECF No. #1 , is dismissed without prejudice. it is further ORDERED that this case is closed. Signed by Judge Jennifer Choe-Groves on 12/8/2023. (apk)
|
| Filing 9 NOTICE of Voluntary Dismissal by Catalyst Pharmaceuticals, Inc., SERB SA as to Inventia Healthcare Limited (Viceconte, Christopher) |
| Filing 8 STANDING ORDER REGARDING CASES IN THE U.S. DISTRICT COURT FOR THE DISTRICT OF DELAWARE. (nmg) |
| Case Reassigned to Judge Jennifer Choe-Groves of the United States Court of International Trade. Please include the initials of the Judge (JCG) after the case number on all documents filed. (rjb) |
| Case Assigned to Judge Gregory B. Williams. Please include the initials of the Judge (GBW) after the case number on all documents filed. (rjb) |
| Filing 7 Summons Issued as to Inventia Healthcare Limited on 11/20/2023. (mpb) |
| Filing 6 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by SERB SA. (mpb) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Catalyst Pharmaceuticals, Inc.. (mpb) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,626,088 ;10,793,893 ;11,060,128 ;11,268,128 ;11,274,331 ;11,274,332. (mpb) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 10/09/2023 & 10/11/2023. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 4/11/2026. (mpb) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb) |
| Filing 1 COMPLAINT filed against Inventia Healthcare Limited ( Filing fee $ 402, receipt number ADEDC-4277841.) - filed by Catalyst Pharmaceuticals, Inc., SERB SA. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Civil Cover Sheet)(mpb) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
